ABK Biomedical

2 clinical trials · Sponsor

Record	Firm	Date
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) (NCT05953337)	ABK Biomedical	2023-09-21
Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC) (NCT04926376)	ABK Biomedical	2021-11-02

Every clearance here is in the API, with alerts when new ones post.